Recent Advances in Esophageal Cancers Go Beyond a One-Size-Fits-All Approach

April 19, 2022

Dr. Nitika Sharma, medical oncologist at Cancer Treatment Centers of America® (CTCA) Atlanta, authored an article in which she explored developments in the esophageal cancer landscape. This timely review was published by Targeted Oncology as part of their coverage for Esophageal Cancer Awareness month.

“A better understanding of the disease biology, identification of actionable genetic alterations and use of immunotherapy is heralding an era of precision therapy for treatment of esophageal cancers.”

Read more here

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.